Expression of multidrug resistance markers ABCB1 (MDR-1/ Pgp) and ABCC1 (MRP-1) in renal cell carcinoma
Citation:
Walsh N, Larkin A, Kennedy S, Connolly L, Ballot J, Ooi W, Gullo G, Crown J, Clynes M, O Driscoll L., Expression of multidrug resistance markers ABCB1 (MDR-1/ Pgp) and ABCC1 (MRP-1) in renal cell carcinoma, BMC Urology, 24, 9, 2009, 6-Download Item:
Abstract:
Background
Renal cell carcinoma patients respond poorly to conventional chemotherapy, this unresponsiveness may be attributable to multidrug resistance (MDR). The mechanisms of MDR in renal cancer are not fully understood and the specific contribution of ABC transporter proteins which have been implicated in the chemoresistance of various cancers has not been fully defined in this disease.
Methods
In this retrospective study the expression of two of these transporter efflux pumps, namely MDR-1 P-gp (ABCB1) and MRP-1 (ABCC1) were studied by immunohistochemistry in archival material from 95 renal cell carcinoma patients.
Results
In the first study investigating MDR-1 P-gp and MRP-1 protein expression patterns in renal cell carcinoma patients, high levels of expression of both efflux pumps are observed with 100% of tumours studied showing MDR-1 P-gp and MRP-1 positivity.
Conclusion
Although these findings do not prove a causal role, the high frequency of tumours expressing these efflux pumps suggests that they may be important contributors to the chemoresistance of this tumour type.
Sponsor
Grant Number
Higher Education Authority (HEA)
Author's Homepage:
http://people.tcd.ie/lodriscDescription:
PUBLISHED
Author: O'DRISCOLL, LORRAINE
Type of material:
Journal ArticleSeries/Report no:
BMC Urology24
9
Availability:
Full text availableKeywords:
Pharmacy and Pharmaceutical SciencesSubject (TCD):
CancerDOI:
http://dx.doi.org/10.1186/1471-2490-9-6Metadata
Show full item recordLicences: